Company registration number 03128776 (England and Wales)
CAVENDISH LABORATORIES LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
CAVENDISH LABORATORIES LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
CAVENDISH LABORATORIES LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
5
25,662
27,287
Current assets
Stocks
12,000
9,000
Debtors
6
265,869
228,433
Cash at bank and in hand
87,814
85,280
365,683
322,713
Creditors: amounts falling due within one year
7
(201,941)
(196,750)
Net current assets
163,742
125,963
Total assets less current liabilities
189,404
153,250
Provisions for liabilities
(6,000)
(7,000)
Net assets
183,404
146,250
Capital and reserves
Called up share capital
1,000
1,000
Profit and loss reserves
182,404
145,250
Total equity
183,404
146,250
The notes on pages 3 to 6 form part of these financial statements.
CAVENDISH LABORATORIES LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 NOVEMBER 2025
30 November 2025
- 2 -
For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved and signed by the director and authorised for issue on 16 June 2026
Mrs R Knight
Director
Company registration number 03128776 (England and Wales)
CAVENDISH LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
1
Accounting policies
Company information
Cavendish Laboratories Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Old Grange, Warren Estate, Lordship Road, Writtle, Essex, UK, CM1 3WT.
The company is part of a group.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales tax.
1.4
Intangible fixed assets other than goodwill
Intangible assets represent patents held by the company, and are recognised at cost and subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Patents & licences
over ten years, fully amortised in 2018
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
15% on reducing balance
Fixtures and fittings
33% on reducing balance
Computers
33% on cost
Motor vehicles
20% on reducing balance
CAVENDISH LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
1.7
Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities, including debtors, creditors and bank balances. Basic short term financial assets are measured at the transaction price, less any impairment and basic short term financial liabilities are measured at the transaction price.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.9
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.10
Leases
As lessee
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
2
Judgements and key sources of estimation uncertainty
No significant judgements or estimations have been applied in the preparation of the financial statements.
CAVENDISH LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 5 -
3
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
13
13
4
Intangible fixed assets
Other
£
Cost
At 1 December 2024 and 30 November 2025
5,000
Amortisation and impairment
At 1 December 2024 and 30 November 2025
5,000
Carrying amount
At 30 November 2025
At 30 November 2024
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 December 2024
110,075
Additions
7,197
Disposals
(5,875)
At 30 November 2025
111,397
Depreciation and impairment
At 1 December 2024
82,788
Depreciation charged in the year
8,561
Eliminated in respect of disposals
(5,614)
At 30 November 2025
85,735
Carrying amount
At 30 November 2025
25,662
At 30 November 2024
27,287
CAVENDISH LABORATORIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 6 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
246,234
212,854
Other debtors
19,635
15,579
265,869
228,433
7
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
53,148
48,657
Taxation and social security
126,271
127,445
Other creditors
22,522
20,648
201,941
196,750
8
Parent company
The company's immediate parent is Cavendish Laboratories Holdings Limited, a company registered in England and Wales whose registered office is The Old Grange, Warren Estate, Lordship Road, Writtle, Essex, CM1 3WT.
The company's ultimate controlling party is R Knight.